Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Ayuna Jombik
Institution:
Kura Oncology (United States)
Observed institution:
Kura Oncology (United States)
ORCID:
0009-0006-5095-3135
Observed ORCID:
0009-0006-5095-3135
OpenAlex ID:
A5125416741
The Farnesyl Transferase Inhibitor Darlifarnib (KO-2806) Resensitizes Relapsing Tumors to RAS Inhibition
2026
·
Hetika Vora Patel
, Alison Elizabeth Smith
, et al.
·
Cancer Research
·
5
PDF
Abstract C084: The farnesyl transferase inhibitor KO-2806 constrains mTORC1 activity to enhance the antitumor efficacy of mutant-selective PI3Kα inhibitors
2025
·
Alison E. Smith
, Ayuna Jombik
, et al.
·
Molecular Cancer Therapeutics
·
1
Figure S5 from The Farnesyl Transferase Inhibitor Darlifarnib (KO-2806) Resensitizes Relapsing Tumors to RAS Inhibition
2026
·
Hetika Vora Patel
, Alison Elizabeth Smith
, et al.
Figure S4 from The Farnesyl Transferase Inhibitor Darlifarnib (KO-2806) Resensitizes Relapsing Tumors to RAS Inhibition
2026
·
Hetika Vora Patel
, Alison Elizabeth Smith
, et al.
Figure S3 from The Farnesyl Transferase Inhibitor Darlifarnib (KO-2806) Resensitizes Relapsing Tumors to RAS Inhibition
2026
·
Hetika Vora Patel
, Alison Elizabeth Smith
, et al.
Table S1 from The Farnesyl Transferase Inhibitor Darlifarnib (KO-2806) Resensitizes Relapsing Tumors to RAS Inhibition
2026
·
Hetika Vora Patel
, Alison Elizabeth Smith
, et al.
Supplementary Methods from The Farnesyl Transferase Inhibitor Darlifarnib (KO-2806) Resensitizes Relapsing Tumors to RAS Inhibition
2026
·
Hetika Vora Patel
, Alison Elizabeth Smith
, et al.
Figure S8 from The Farnesyl Transferase Inhibitor Darlifarnib (KO-2806) Resensitizes Relapsing Tumors to RAS Inhibition
2026
·
Hetika Vora Patel
, Alison Elizabeth Smith
, et al.
Figure S1 from The Farnesyl Transferase Inhibitor Darlifarnib (KO-2806) Resensitizes Relapsing Tumors to RAS Inhibition
2026
·
Hetika Vora Patel
, Alison Elizabeth Smith
, et al.
Figure S6 from The Farnesyl Transferase Inhibitor Darlifarnib (KO-2806) Resensitizes Relapsing Tumors to RAS Inhibition
2026
·
Hetika Vora Patel
, Alison Elizabeth Smith
, et al.
Data from The Farnesyl Transferase Inhibitor Darlifarnib (KO-2806) Resensitizes Relapsing Tumors to RAS Inhibition
2026
·
Hetika Vora Patel
, Alison Elizabeth Smith
, et al.
Figure S7 from The Farnesyl Transferase Inhibitor Darlifarnib (KO-2806) Resensitizes Relapsing Tumors to RAS Inhibition
2026
·
Hetika Vora Patel
, Alison Elizabeth Smith
, et al.
Figure S2 from The Farnesyl Transferase Inhibitor Darlifarnib (KO-2806) Resensitizes Relapsing Tumors to RAS Inhibition
2026
·
Hetika Vora Patel
, Alison Elizabeth Smith
, et al.
Show more works
View as search
Works count:
13
Citation count:
6
H-index:
1
I10-index:
Year
Topic
Type